Cantitate/Preț
Produs

Psychiatric Drugs Explained

De (autor)
Notă GoodReads:
en Limba Engleză Carte Paperback – 06 Apr 2016

Now in its sixth edition, and written by an author internationally recognised in his field, Psychiatric Drugs Explained offers a wealth of information in a handy easy-to-use format. Organised by disorder, and providing a comprehensive review of drug effects, action and side-effects, this fully updated new edition covers the latest drugs on the market, and explores changes in prescribing practice.
The author's approach is distinctive and reader-friendly, to help guide mental health professionals through the benefits and impacts of psychotropic drugs. Additional topics include management of disorders including stimulants and drugs for children, cognitive impairment and sleep disorders.

Citește tot Restrânge

Preț: 14497 lei

Preț vechi: 15261 lei
-5%

Puncte Express: 217

Preț estimativ în valută:
2963 3485$ 2649£

Carte disponibilă

Livrare economică 08-13 octombrie
Livrare express 29 septembrie-03 octombrie pentru 4030 lei

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780702045080
ISBN-10: 070204508X
Pagini: 360
Ilustrații: Illustrated
Dimensiuni: 234 x 156 x 17 mm
Greutate: 0.59 kg
Ediția: 6 Rev ed.
Editura: Elsevier

Public țintă

Psychiatric Drugs Explained will be ideal for mental health nurses, MRCPsych students, as well as social workers in mental health, clinical psychologists, pharmacologists and pharmacology students, community mental health professionals and GPs, advocacy and user groups in mental health, users and their families.

Cuprins

Treatment
Section 1 Management of the psychoses
2 The antipsychotics
3 Antipsychotic side effects and their management
References
Section 2 Management of depression
4 The antidepressants
5 Side effects of antidepressants
References
Section 3 Management of bipolar disorders
6 Management of acute bipolar disorder
7 Mood-stabilisers
References
Section 4 Stimulants & Drugs for children
8 Stimulants & Drugs for children
References
Section 5 Management of anxiety
8 The anxiety disorders
10 Benzodiazepine anxiolytics
11 Anxiolysis and the serotonin system
12 Beta-blockers and anxiety
References
Section 6 Management of sleep disorders and insomnia
13 Sleep disorders and insomnia
14 Non-pharmacological management of insomnia
15 Hypnotics
16 Sedatives
References
Section 7 Management of cognitive impairment
17 Cognitive enhancement and the dementias
18 Cognitive enhancement and neuroprotection
References
Section 8 Management of sexual difficulties
19 The range of sexual difficulties
20 Effects of drugs on aspects of sexual functioning
Appendix 20.1 Male sexual functioning questionnaire
Appendix 20.2 Female sexual functioning questionnaire
References
Section 9 Management of dependence and withdrawal
21 Dependence & Withdrawal
22 Dependence & Craving
23 Dependence & Protracted Withdrawal
References
Section 10 Consent, abuse and liability
24 Consent
25 Pharmacological abuse
References
Section 11 The marketing of tranquillity
26 The ethical industry
27 Evidence-biased care
28 Marketing & Risk
29 From healthcare to pharmageddon